Smith & Nephew plc  

(Public, LON:SN)   Watch this stock  
Find more results for SN
1,089.00
+22.00 (2.06%)
Real-time:   3:31PM GMT
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,071.00 - 1,093.00
52 week 1,006.20 - 1,217.00
Open 1,075.00
Vol / Avg. 1.54M/2.37M
Mkt cap 9.81B*
P/E 34.38
Div/yield 13.03/1.95*
EPS 0.32*
Shares 896.62M
Beta     -
Inst. own     -
*GBP
May 5, 2016
Q1 2016 Smith & Nephew PLC Trading Statement Release Add to calendar
Apr 14, 2016
Smith & Nephew PLC Annual Shareholders Meeting Add to calendar
Apr 8, 2016
Smith & Nephew PLC Annual Shareholders Meeting (Estimated) - 2:00PM GMT+1 - Add to calendar
Feb 4, 2016
Q4 2015 Smith & Nephew PLC Earnings Call - Webcast
Feb 4, 2016
Q4 2015 Smith & Nephew PLC Earnings Release
Nov 18, 2015
Smith & Nephew PLC at Jefferies Autumn Global Healthcare Conference
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 4.87% 8.85%
Operating margin 8.00% 13.51%
EBITD margin - 30.34%
Return on average assets 3.19% 5.67%
Return on average equity 5.72% 10.24%
Employees 14,000 -
CDP Score - 95 B

Address

15 Adam Street
LONDON, WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company's Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Company's Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 56
Julie Brown Chief Financial Officer, Executive Director
Age: 52
Rodrigo Bianchi President, IRAMEA
Age: 55
Michael G. Frazzette President - Advanced Surgical Devices
Age: 53
R. Gordon Howe President - Global Operations
Age: 52
Diogo Moreira-Rato President - Europe and Canada
Age: 53
Glenn S. Warner President - Advanced Wound Management
Age: 52
John W. Campo Chief Legal Officer
Age: 60
Helen Maye Chief Human Resources Officer
Age: 55
Cyrille Petit Chief Corporate Development Officer
Age: 44